Open access
Jul 2026
RfxCas13d mediates robust cross-strain suppression of highly pathogenic avian influenza viruses
A programmable RNA-targeting antiviral platform based on RfxCas13d is developed and its activity in avian cells is evaluated, establishing RfxCas13d as a versatile RNA-guided antiviral platform and providing a foundation for cross-strain influenza control through conserved RNA targeting.
Sudip Dhakal, Aaron J. Smith, Emiliana Weiss et al.
· npj Antimicrobials and Resis... · 0 citations